Search alternatives:
implement » implementing (Expand Search)
Showing 401 - 420 results of 107,686 for search '(complement OR implement)', query time: 0.22s Refine Results
  1. 401
  2. 402
  3. 403

    Isolation and Characterization of a New Peroxisome Deficient CHO Mutant Cell Belonging to Complementation Group 12 by K. Ghaedi

    Published 2009-09-01
    “…By this method, we have isolated one CHO cell mutant, ZPEG403, which was found to belong to complementation group G (CG-G). Expression of the human peroxin, Pex3p cDNA encoding a 373-amino-acid peroxisomal membrane protein morphologically and biochemically restored peroxisome biogenesis, including peroxisomal membrane assembly, in ZPEG403 cells. …”
    Get full text
    Article
  4. 404

    The predictive value of NLR, SII, and complement 3 in treatment response for systemic lupus erythematosus with immune thrombocytopenia by Ziqiang Zheng, Ziqiang Zheng, Jiali Liu, Taoyuan He, Taoyuan He, Chang Liu

    Published 2025-07-01
    “…The median SII values were 145.7 (43.7-238.7) for the CR group, 57.2 (20.5-90.2) for the PR group, and 117.8 (80.7-238.6) for the NR group. Additionally, complement 3 levels were significantly lower in the CR group compared to the PR and NR groups (P=0.010). …”
    Get full text
    Article
  5. 405
  6. 406
  7. 407
  8. 408

    Visualizing interactions along the Escherichia coli twin-arginine translocation pathway using protein fragment complementation. by Jan S Kostecki, Haiming Li, Raymond J Turner, Matthew P DeLisa

    Published 2010-02-01
    “…To visualize these interactions, we have adapted bimolecular fluorescence complementation (BiFC) to detect protein-protein interactions along the Tat pathway of living cells. …”
    Get full text
    Article
  9. 409

    The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway by Nancy A. Turner, Joel L. Moake

    Published 2025-03-01
    “…Abstract The immediate defense provided by the alternative complement pathway (AP) is under constant control by fluid phase regulators, factor H (FH) and factor I (FI), to prevent nonessential activation. …”
    Get full text
    Article
  10. 410

    Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case report by Leonore Ingold, Michael Dickenmann, Thomas Menter, Helmut Hopfer, Patricia Hirt-Minkowski

    Published 2025-06-01
    “…Iptacopan is an oral inhibitor of complement factor B that effectively blocks the alternative complement pathway. …”
    Get full text
    Article
  11. 411
  12. 412

    Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system. by Eija Nissilä, François P Douillard, Jarmo Ritari, Lars Paulin, Hanna M Järvinen, Pia Rasinkangas, Karita Haapasalo, Seppo Meri, Hanna Jarva, Willem M de Vos

    Published 2017-01-01
    “…The capacity of the L. rhamnosus strains to activate serum complement was studied using immunological assays for complement factor C3a and the terminal pathway complement complex (TCC). …”
    Get full text
    Article
  13. 413
  14. 414

    Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity by Yuanyuan Li, Wen Wu, Qihui Liu, Qiong Wu, Ping Ren, Xi Xi, Haiyan Liu, Jiarui Zhao, Wei Zhang, Zizhun Wang, Yuanyuan lv, Bin Tian, Shuang Sun, Jiaqi Cui, Yangyang Zhao, Jingyuan Wu, Mingyuan Gao, Fangfang Chen

    Published 2024-11-01
    “…Mechanistically, IONP-COOH indirectly binds to C3b after activating the complement alternative pathway, subsequently enhancing phagocytosis of macrophages and activating adaptive immunity mediated by complement corona. …”
    Get full text
    Article
  15. 415
  16. 416

    Complement-Mediated Hemolytic Uremic Syndrome Due to MCP/CD46 Mutation: A Case Report by Abdul Muhsen Abdeen MD, Jowan Al-Nusair MD, Malik Samardali MD, Mohamed Alshal MD, Amro Al-Astal MD, Zeid Khitan MD

    Published 2025-01-01
    “…Thrombotic microangiopathy (TMA) is a severe condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage, often involving the kidneys. Complement-mediated hemolytic uremic syndrome (cHUS), a rare form of TMA, arises from dysregulated alternative complement pathway activation, frequently due to genetic mutations. …”
    Get full text
    Article
  17. 417

    The Study of Serum Complement C3, C4 and Immunoglobulin E IgE in Psoriasis Patients by Baghdad Science Journal

    Published 2015-12-01
    “…The present study was aimed to find out the role of humoral immunity in the pathogenesis of psoriasis. Complements C3, C4 and immunoglobulin IgE .The study included 55 Iraqi patients with psoriasis 30 (15 females ,15 males) were untreated with any drugs. …”
    Get full text
    Article
  18. 418

    Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System by Marie Delafontaine, Isadora Maria Villas-Boas, Giselle Pidde, Carmen W. van den Berg, Laurence Mathieu, Joël Blomet, Denise V. Tambourgi

    Published 2018-01-01
    “…Here, we investigated the ability of B. lanceolatus venom to activate the Complement system (C) in order to improve the understanding of venom-induced local inflammation. …”
    Get full text
    Article
  19. 419
  20. 420